{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:04Z","timestamp":1786119604748,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,15]]},"DOI":"10.1097\/qai.0b013e3181fba6ab","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T01:44:32Z","timestamp":1287798272000},"page":"635-640","source":"Crossref","is-referenced-by-count":29,"title":["Using Different Calculations of Pharmacy Refill Adherence to Predict Virological Failure Among HIV-Infected Patients"],"prefix":"10.1097","volume":"55","author":[{"given":"I Marion","family":"de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam A G","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pythia T","family":"Nieuwkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210131","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/507526","article-title":"Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.","volume":"43","author":"Bangsberg","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R2-16-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"R3-16-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11904-007-0027-4","article-title":"Use of pharmacy refill data as a measure of antiretroviral adherence.","volume":"4","author":"Grossberg","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0b013e3281532b31","article-title":"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.","volume":"21","author":"Braithwaite","year":"2007","journal-title":"AIDS"},{"key":"R5-16-20210131","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1086\/507680","article-title":"A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.","volume":"194","author":"Gross","year":"2006","journal-title":"J Infect Dis"},{"key":"R6-16-20210131","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jclinepi.2004.04.002","article-title":"A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.","volume":"57","author":"Grossberg","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1258\/0956462042563666","article-title":"Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death.","volume":"15","author":"Kitahata","year":"2004","journal-title":"Int J STD AIDS"},{"key":"R8-16-20210131","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1468-1293.2009.00696.x","article-title":"Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.","volume":"10","author":"Knobel","year":"2009","journal-title":"HIV Med"},{"key":"R9-16-20210131","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/426595","article-title":"Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.","volume":"40","author":"Maggiolo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clinthera.2007.04.006","article-title":"Association between pharmacy medication refill-based adherence rates and CD4 count and viral-load responses: a retrospective analysis in treatment-experienced adults with HIV.","volume":"29","author":"Townsend","year":"2007","journal-title":"Clin Ther"},{"key":"R11-16-20210131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","article-title":"Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.","volume":"146","author":"Nachega","year":"2007","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","article-title":"Practical and conceptual challenges in measuring antiretroviral adherence.","volume":"43","author":"Berg","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-16-20210131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09540120701694006","article-title":"Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression.","volume":"20","author":"Saberi","year":"2008","journal-title":"AIDS Care"},{"key":"R14-16-20210131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications.","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.pmed.0050109","article-title":"Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.","volume":"5","author":"Bisson","year":"2008","journal-title":"PLoS Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181fba6ab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:38Z","timestamp":1786041758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201012150-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,15]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181fba6ab","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,15]]}}}